Cargando...
Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study
Current guidelines suggest treatment with corticosteroids (CS) in IgA nephropathy (IgAN) when proteinuria is persistently ≥1 g/d despite 3–6 months of supportive care and when eGFR is >50 ml/min per 1.73 m(2). Whether the benefits of this treatment extend to patients with an eGFR≤50 ml/min per 1....
Guardado en:
| Publicado en: | J Am Soc Nephrol |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Nephrology
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4552116/ https://ncbi.nlm.nih.gov/pubmed/25677392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014070697 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|